Primary Record
p-DPO
- In stock
- 8,406 g
- Purity
- 99.8 %
- CAS
- 131089-08-2
Compound Identifiers & Properties
- CAS
- 131089-08-2
- PubChem CID
- 84027
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)COC6=CC=C(C=C6)O)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)COc2ccc(O)cc2)[C@H](O)[C@H](C)O1
Names & Synonyms
- p-DPO
- Doxorubicin-N-4-hydroxyphenoxyacetamide
- RefChem:135733
- AC1L36ND
- DTXSID50156889
- DTXCID6079380
- C35H35NO14
- CID84027
- C35-H35-N-O14
- 131089-08-2
- N-[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]-2-(4-hydroxyphenoxy)acetamide
- (1S,3S)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[2-(4-hydroxyphenoxy)acetamido]-alpha-L-lyxo-hexopyranoside
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(((4-hydroxyphenoxy)acetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-